お問い合わせフォームに入力の上、ご送信ください。詳細は折り返しメールでお伺いしますので簡単で結構です。
構造式をクリックして表示される詳細画面からでもお問い合わせいただけます。
SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
---|---|---|---|---|---|
05950 | Sulforhodamine bis(CO-PEG14-COOH) | 68,800/0.1mg | >95% | 1.6 | |
06798 | Cy5(1-PEG3-OMe 5-SO3H 8,8-diMe 1'-PEG13-COOH 8',8'-diMe) | 133,000/0.1mg | >95% | 0.1 | |
06461 | Cy5(PEG3-OMe)(PEG13-COOtBu) | 133,000/0.1mg | >95% | 0 | |
06410 | Cy7(1-PEG13-COOH 5-SO3H 8,8-diMe 1'-PEG3-OMe 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >95% | 0.4 | |
06401 | TMSI-PEG13-OTrt | 68,800/0.1mg | >95% | 0 | |
06396 | AADIS7-PEG13-COOH | 133,000/0.1mg | >95% | 0.3 | |
06390 | AADIS7-PEG13-COOtBu | 105,500/0.1mg | >95% | 0.9 | |
06311 | TMSI-PEG13-COOH | 68,800/0.1mg | >95% | 11.1 | |
06064 | Cy7(1-HexCONH-PEG13-COOtBu 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 | |
05373 | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-CONH-PEG2-Hex-Cl 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >90% | 0.1 | |
05078 | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-COOtBu 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >90% | 0 | |
04746 | CF660R-PEG13-PEG2-O-HexCl | 133,000/0.1mg | >95% | 0.1 | |
04731 | DY-547-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 | |
04730 | Texas-Red-X-CONH-PEG13-COOH mixed isomers | 69100/<0.1mg | >95% | 0.1 | |
06479 | Cy5(1-PEG12-OMe 5-SO3H 8,8-diMe 1'-AcOtBu-8',8'-diMe | 68,800/0.1mg | >90% | 0.4 | |
06456 | TMSI-PEG12-OMe | 68,800/0.1mg | >80% | 9.0 | |
06394 | TMSI-PEG12-OH | 133,000/0.1mg | >95% | 6.1 | |
06363 | SH-PEG12-SH | 75,000/2.5mg | >90% | 0 | |
06354 | Cyclic(-S-PEG12-S-) | 71,500/0.1mg | >95% | 0 | |
06338 | SCSOEt-PEG12-SCSOEt | 65,700/0.4mg | >90% | 0 | |
06518 | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Et 5'-SO3H 8'-Me 8'-PEG11-OMe | 68,800/0.1mg | >90% | 0 | |
06362 | SH-PEG11-SH | 71,500/0.2mg | >90% | 0 | |
06402 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG10-OAc 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 | |
06361 | SH-PEG10-SH | 68,400/0.4mg | >90% | 0 | |
06356 | Cyclic(-S-PEG10-) | 84,900/0.1mg | >95% | 0 | |
06355 | Cyclic(-S-PEG4-S-PEG6-) | 84,900/0.1mg | >95% | 0 | |
06069 | TMSI-PEG10-OH | 68,800/0.1mg | >95% | 0.1 | |
06375 | Cyclic(-S-PEG9-) | 84,900/0.1mg | >95% | 3.5 | |
06068 | TMSI-PEG10-OTrt | 63,400/0.2mg | >95% | 9.0 | |
02749 | OH-PEG9-SO3H | 64,000/0.7mg | >95% | 16.2 | |
01749 | SCSOEt-PEG9-SCSOEt | 72,300/2.5mg | >95% | 0 | |
01724 | SH-PEG9-SH | 75,000/2.5mg | >90% | 44.3 | |
06360 | SH-PEG8-SH | 88,400/2.5mg | >90% | 0 | |
06349 | Cyclic(-S-PEG5-S-PEG3-) | 84,900/0.1mg | >95% | 0 | |
06295 | TMSI-PEG8-OH | 64,000/0.7mg | >95% | 12.8 | |
00369 | N3-PEG8-COOH | 78,900/2.5mg | >95% | 0 | |
06398 | TMSI-PEG7-OH | 64,000/0.7mg | >95% | 1.3 | |
06359 | SH-PEG7-SH | 80,100/0.7mg | >90% | 0 | |
06350 | Cyclic(-S-PEG7-S-PEG1-) | 84,900/0.1mg | >95% | 0 | |
06516 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 | |
06432 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06417 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 | |
06397 | TMSI-PEG6-OH | 64,000/0.7mg | >95% | 1.2 | |
01794 | SH-PEG6-SH | 64,000/0.7mg | >90% | 0 | |
06796 | AADIS5-PEG5-COOH | 64,000/0.7mg | >95% | 0 | |
06453 | SCNHNH2-PEG5-SCNHNH2 | 68,900/25mg | >95% | 335.0 | |
06426 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 | |
06419 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 | |
06377 | Cyclic(-S-PEG5-) | 84,900/0.1mg | >95% | 0 | |
06357 | SH-PEG5-SH | 64,000/0.7mg | >90% | 0 | |
06294 | TMSI-PEG5-NHTrt | 68,800/0.1mg | >95% | 2.6 | |
05343 | DMT-PEG5-S-PEG4-ODMT | 68,800/500mg | >80% | 2,114.2 | |
04857 | Sulforhodamine bis(piperazine-PEG5-COOH) | 65,700/0.4mg | >95% | 7.0 | |
04743 | DMT-PEG5-S-Et-OH | 66,300/25mg | >90% | 300.6 | |
06511 | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 | |
06509 | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06508 | Tos-PEG4-SCSOEt | 72,300/25mg | >95% | 271.5 | |
06473 | DMSI(3-PEG4-COOH) | 64,000/0.7mg | >95% | 4.1 | |
06434 | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06433 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG3-OMe) | 68,800/0.1mg | >90% | 0 | |
06422 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 | |
06409 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-N3 8',8'-diMe) | 133,000/0.1mg | >95% | 0 | |
06405 | AADIS7-PEG4-N3 | 68,800/0.1mg | >95% | 2.5 | |
06387 | SCSOEt-PEG4-SCSOEt | 66,300/25mg | >90% | 669.7 | |
06384 | Cyclic(-S-PEG4-S-)9 | 149,100/0.1mg | >95% | 0.1 | |
06383 | Cyclic(-S-PEG4-S-)8 | 149,100/0.1mg | >90% | 0.1 | |
06382 | Cyclic(-S-PEG4-S-)7 | 149,100/0.1mg | >90% | 0.1 | |
06381 | Cyclic(-S-PEG4-S-)6 | 149,100/0.1mg | >90% | 0.1 | |
06380 | Cyclic(-S-PEG4-S-)5 | 149,100/0.1mg | >90% | 0.1 | |
06379 | Cyclic(-S-PEG4-S-)4 | 149,100/0.1mg | >90% | 0.1 | |
06378 | Cyclic(-S-PEG4-S-)3 | 149,100/0.1mg | >90% | 0.1 | |
06353 | Cyclic(-S-PEG4-S-)4 | 83,800/0.1mg | >95% | 0 | |
06352 | Cyclic(-S-PEG4-S-)3 | 83,800/0.1mg | >95% | 0 | |
06343 | Cyclic(-S-PEG4-S-)2 | 149,100/0.1mg | >95% | 0.1 | |
06340 | SH-PEG4-SS-PEG4-SH | 84,100/0.7mg | >90% | 34.0 | |
06293 | TMSI-PEG4-Pr-COOH | 64,000/0.7mg | >95% | 0 | |
06062 | Cy7(1-PEG4-COOH 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 | |
06059 | AADIS7-PEG4-COOMe | 133,000/0.1mg | >95% | 3.9 | |
06009 | Cy7(1-PEG4-COOMe 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 | |
05970 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-OH 8',8'-diMe) | 68,800/0.1mg | >95% | 0 | |
05948 | TMSI-PEG4-OH | 68,800/0.2mg | >95% | 15.7 | |
05344 | DMT-PEG4-S-Et-OAc | 64,900/75mg | >80% | 426.3 | |
05075 | AADIS7-PEG3-OAc | 65,700/0.4mg | >95% | 3.0 | |
04712 | SH-PEG4-SH | inquire | >90% | 60.0 | |
04674 | SCNHNH2-PEG4-SCNHNH2 | 68,900/25mg | >95% | 1,350.9 | |
04673 | Tos-PEG4-SCNHNH2 | 63,400/50mg | >95% | 776.1 | |
04243 | DMT-PEG4-SCSOEt | 72,300/25mg | >95% | 158.6 | |
03828 | Trt-PEG3-S-Et-OH | 65,300/10mg | >90% | 408.1 | |
03545 | TMSI-PEG4-COOMe | 68,800/0.1mg | >95% | 1.6 | |
02292 | DMT-PEG4-SS-PEG4-OTos | 72,500/5mg | >95% | 30.8 | |
02196 | Trt-PEG4-SH | 68,100/0.2mg | >95% | 1.8 | |
02194 | DMT-PEG4-SS-Et-OH | 70,000/25mg | >95% | 371.1 | |
02193 | Trt-PEG4-SS-Et-OTos | 72,500/5mg | >95% | 0 | |
01266 | Trt-PEG4-SS-PEG4-N3 | 70,800/2.5mg | >90% | 0 | |
06512 | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 | |
06450 | (OH-PEG3-S-)2 | 80,100/0.7mg | >95% | 7.2 | |
06431 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 | |
06430 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 | |
06425 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 | |
06423 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 | |
06421 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06420 | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06393 | TMSI-PEG3-OMe | 64,000/0.7mg | >95% | 11.2 | |
06358 | SH-PEG3-SH | inquire | >90% | 1.3 | |
06351 | Cyclic(-S-PEG3-S-PEG1-)2 | 84,900/0.1mg | >95% | 0 | |
06346 | Cyclic(-S-PEG3-S-CH2-O-CH2-)2 | 84,900/0.1mg | >95% | 0 | |
06342 | Cyclic(-S-PEG3-S-)2 | 84,900/0.1mg | >95% | 0 | |
06341 | SH-PEG3-SS-PEG3-SH | 84,100/0.7mg | >90% | 0 | |
06061 | Cy7(1-Hex-COOH 5-SO3H 8,8-diMe 1'-PEG3-OAc 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 | |
05146 | TMSI-PEG3-OH | 68,800/0.1mg | >95% | 89.4 | |
03842 | N3-PEG3-O-Et-SS-Et-PEG3-OH | 75,200/5mg | >95% | 38.9 | |
03032 | DMT-PEG3-NH-Et-SS-Et-NH2 | 70,800/2.5mg | >95% | 37.9 | |
02597 | Trt-PEG3-PPG1-SO3H | 64,900/7.5mg | >95% | 186.0 | |
02345 | TrtNH-PEG3-NHCO-Et-S-COMe | 64,000/5mg | >95% | 98.0 | |
02065 | Trt-PEG3-SSO3H | 64,600/0.5mg | >95% | 26.8 | |
01905 | N3-PEG3-SCSOEt | 67,300/0.5mg | >95% | 77.4 | |
01636 | SO3H-PEG3-OH | 67,300/0.5mg | <80% | 60.0 | |
01551 | Trt-PEG3-SCSOEt | 64,900/7.5mg | >95% | 241.0 | |
01331 | Cy5(1-Hex-CONH-PEG3-NH2 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 64,000/0.7mg | >90% | 0 | |
06515 | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06513 | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | 68,800/0.1mg | >95% | 0 | |
06510 | Cy7(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG2-OMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 | |
06440 | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 | |
06439 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 | |
02195 | TrtNH-PEG1-S-Et-OH | 70,000/25mg | >90% | 136.0 | |
01699 | SCSOEt-PEG2K-SCSOEt | 66,300/2.5mg | <80% | 353.0 | |
06523 | Cy7(1-PEG4-COOH 5-SO3H 8,8-di-Me 1'-PEG4-COOH 5'-SO3H 8',8'-diMe)(4-Et-SO3H) | 68,800/0.1mg | >95% | 0 | |
06522 | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 | |
06521 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06520 | Cy5(1-PEG4-Pr-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PE4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >90% | 0 | |
06519 | Cy7(1-HexCOOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 | |
06514 | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
06446 | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | 68,800/0.1mg | >95% | 0 | |
06418 | Cy7(1-PEG5-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 | |
06416 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 | |
01980 | Cy3-halolinker | 63,400/0.2mg | >95% | 0.1 |